|

Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital

RECRUITINGSponsored by Sohag University
Actively Recruiting
SponsorSohag University
Started2025-03-12
Est. completion2025-09-12
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT06953921

Summary

assess the correlation between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. assess the impact of albumin level on clinical course and outcomes of HE.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* patients aged \>18 years.
* Confirmed chronic liver disease (by imaging ,
* liver function tests , and clinical history).
* Diagnosed with hepatic encephalopathy based on clinical criteria.
* Patients able to provide informed consent.

Exclusion Criteria:

* Patients age less than 18 years old
* Acute liver failure.
* Chronic renal failure on dialysis.
* Pregnant women.
* Patients with active malignancy.

Conditions2

Hepatic EncephalopathyLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.